A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Neuroblastoma, Wilm's Tumors and other Pediatric Cancers Bookmark and Share

Neuroblastoma, Wilm's Tumor and Other Pediatric Cancers

The Pediatric Oncology Program at City of Hope offers comprehensive, family-centered, leading-edge treatment for childhood, adolescent and young adult (AYA) patients with neuroblastoma, Wilms Tumor and a wide variety of other benign and malignant solid tumors that require expert care to offer the best chance of cure.

Neuroblastoma
Neuroblastoma, a cancer that develops in immature nerve cells, represents a diagnostic and treatment dilemma that requires expert understanding of the tumor’s biology. At City of Hope, our ground-breaking work in both laboratory science and patient care gives us the experience to determine whether the individual diagnosis calls for observation or for the most aggressive approach.
 
City of Hope is a member of the Children’s Oncology Group (COG), which provides access to the nation’s largest group of pediatric and adolescent clinical trials for neuroblastoma with treatments that include chemotherapy, autologous hematopoietic cell transplant (HCT), retinoic acid therapy and antibody therapy (anti-Ch14.18) for aggressive neuroblastoma. City of Hope scientists are working on several research initiatives to develop new therapies for neuroblastoma. Pediatric team members are collaborating on research efforts to bring these therapies to clinical practice.

Wilm's Tumor
Wilm’s tumor is a cancer of the kidney that is curable in most diagnosed children, with a survival rate of more than 90 percent. Usually only surgery and chemotherapy are needed to successfully treat Wilm’s tumor, but in difficult cases, more aggressive treatment, including radiation therapy, may be required. Our long-standing expertise in autologous hematopoietic cell transplant (HCT) enables aggressive treatment in patients with very advanced disease.
 
City of Hope is a member of the Children’s Oncology Group (COG), which provides access to the nation’s largest group of pediatric and adolescent clinical trials for Wilms tumor.

Other Solid Tumors
Children, adolescents and young adults can have many other types of tumors. As a National Cancer Institute-designated Comprehensive Cancer Center, City of Hope is prepared to deliver the best care available with its experienced pediatric oncology team. City of Hope is a member of the Children’s Oncology Group (COG), which provides access to the nation’s largest group of pediatric and adolescent clinical trials for the variety of cancers seen in children, adolescents and young adults. City of Hope offers expert treatment for the following diseases:
 
  • Germ cell tumors
  • Testicular or ovarian tumors
  • Thyroid cancer*
  • Melanoma
  • Carcinoma of head/neck, including larynx or tongue
  • Rare tumors of children, adolescents and young adults
     
*City of Hope is one of an elite few centers in Southern California offering comprehensive care with collaboration between endocrinology and pediatric oncology.
 
Neuroblastoma, Wilm’s tumor and the other tumors seen in children, adolescents and young adults require a team of experienced professionals to provide comprehensive and family-centered care.  At City of Hope, our pediatric team specializes in the treatment of children, adolescents and young adults from birth to 30 years of age. The team includes social workers; child life specialists; recreation, occupational and physical rehabilitation therapists; school reintegration specialists; nutritionists; psychologists; neuropsychologists; and spiritual care specialists.

Meet our team:
 
Clarke Anderson, M.D.
Julie DiMundo, D.O.
James F. Miser, M.D.
Jeanelle Folbrecht, Ph.D.
Natalie Kelly, Ph.D.
Alison Bell, C.P.N.P.
Lisa Gutierrez, P.N.P.
Kayla Fulginiti, M.S.W.
 
In addition to the best medical care available, we also provide access to several support programs, including:
 
  • The  Biller Patient and Family Resource Center
  • Unique support programs for adolescents and young adults (AYA) to assist with the often difficult transition into adulthood at the time of illness
  • Late effects/survivor clinic works with patients long after their treatment to identify, treat and counsel for any issue that might arise related to their life-saving treatment

Our physicians are leading research to find better treatments for children, adolescents and young adults with these tumors. For more information on our pediatric research, including ongoing clinical trials, visit City of Hope’s Clinical Trials Online website.
 

Neuroblastoma, Wilm's Tumors and other Pediatric Cancers

Neuroblastoma, Wilm's Tumor and Other Pediatric Cancers

The Pediatric Oncology Program at City of Hope offers comprehensive, family-centered, leading-edge treatment for childhood, adolescent and young adult (AYA) patients with neuroblastoma, Wilms Tumor and a wide variety of other benign and malignant solid tumors that require expert care to offer the best chance of cure.

Neuroblastoma
Neuroblastoma, a cancer that develops in immature nerve cells, represents a diagnostic and treatment dilemma that requires expert understanding of the tumor’s biology. At City of Hope, our ground-breaking work in both laboratory science and patient care gives us the experience to determine whether the individual diagnosis calls for observation or for the most aggressive approach.
 
City of Hope is a member of the Children’s Oncology Group (COG), which provides access to the nation’s largest group of pediatric and adolescent clinical trials for neuroblastoma with treatments that include chemotherapy, autologous hematopoietic cell transplant (HCT), retinoic acid therapy and antibody therapy (anti-Ch14.18) for aggressive neuroblastoma. City of Hope scientists are working on several research initiatives to develop new therapies for neuroblastoma. Pediatric team members are collaborating on research efforts to bring these therapies to clinical practice.

Wilm's Tumor
Wilm’s tumor is a cancer of the kidney that is curable in most diagnosed children, with a survival rate of more than 90 percent. Usually only surgery and chemotherapy are needed to successfully treat Wilm’s tumor, but in difficult cases, more aggressive treatment, including radiation therapy, may be required. Our long-standing expertise in autologous hematopoietic cell transplant (HCT) enables aggressive treatment in patients with very advanced disease.
 
City of Hope is a member of the Children’s Oncology Group (COG), which provides access to the nation’s largest group of pediatric and adolescent clinical trials for Wilms tumor.

Other Solid Tumors
Children, adolescents and young adults can have many other types of tumors. As a National Cancer Institute-designated Comprehensive Cancer Center, City of Hope is prepared to deliver the best care available with its experienced pediatric oncology team. City of Hope is a member of the Children’s Oncology Group (COG), which provides access to the nation’s largest group of pediatric and adolescent clinical trials for the variety of cancers seen in children, adolescents and young adults. City of Hope offers expert treatment for the following diseases:
 
  • Germ cell tumors
  • Testicular or ovarian tumors
  • Thyroid cancer*
  • Melanoma
  • Carcinoma of head/neck, including larynx or tongue
  • Rare tumors of children, adolescents and young adults
     
*City of Hope is one of an elite few centers in Southern California offering comprehensive care with collaboration between endocrinology and pediatric oncology.
 
Neuroblastoma, Wilm’s tumor and the other tumors seen in children, adolescents and young adults require a team of experienced professionals to provide comprehensive and family-centered care.  At City of Hope, our pediatric team specializes in the treatment of children, adolescents and young adults from birth to 30 years of age. The team includes social workers; child life specialists; recreation, occupational and physical rehabilitation therapists; school reintegration specialists; nutritionists; psychologists; neuropsychologists; and spiritual care specialists.

Meet our team:
 
Clarke Anderson, M.D.
Julie DiMundo, D.O.
James F. Miser, M.D.
Jeanelle Folbrecht, Ph.D.
Natalie Kelly, Ph.D.
Alison Bell, C.P.N.P.
Lisa Gutierrez, P.N.P.
Kayla Fulginiti, M.S.W.
 
In addition to the best medical care available, we also provide access to several support programs, including:
 
  • The  Biller Patient and Family Resource Center
  • Unique support programs for adolescents and young adults (AYA) to assist with the often difficult transition into adulthood at the time of illness
  • Late effects/survivor clinic works with patients long after their treatment to identify, treat and counsel for any issue that might arise related to their life-saving treatment

Our physicians are leading research to find better treatments for children, adolescents and young adults with these tumors. For more information on our pediatric research, including ongoing clinical trials, visit City of Hope’s Clinical Trials Online website.
 
Patient Care Overview

City of Hope Locations

Faces of Cancer

Meet City of Hope patients and their families.
 
 
Clinics/Treatments/Services
As a Comprehensive Cancer Center – the highest designation given by the National Cancer Institute – we are widely regarded as a leader in cancer prevention and treatment.

Cancer Expertise Matters


NEWS & UPDATES
  • It was 2009 when a City of Hope patient in her 40s learned that the cancer she had been fighting for several years had metastasized to her lungs. Her medical team ran genetic tests on the tumor, but none of the drug therapies available at the time targeted the known mutations in the tumor cells. […]
  • Acute myeloid leukemia (AML) is characterized by a rapidly-developing cancer in the myeloid line of blood cells, which is responsible for producing red blood cells, platelets and several types of white blood cells called granulocytes. Because AML grows rapidly, it can quickly crowd out normal blood cells, leadi...
  • Rachel Divine is a yoga therapist and patient leader for the Sheri & Les Biller Patient and Family Resource Center. She’s also a former City of Hope patient. When someone you know has cancer, even the word “cancer” can make you feel nervous, sleepless, depressed or more. But, as a yoga teacher for 15 ...
  •   Diagnosed with type 1 diabetes when she was 9 years old, Gina Marchini accepted the fact that she would need insulin the rest of her life. Every day, she injected herself with the lifesaving hormone. She also carefully controlled her diet and monitored the rise and fall of her blood glucose with military...
  • The defeat of cancer will require a team effort. Nowhere is this more necessary (or apparent) than in efforts to combat two of the most deadly forms of the disease  – pancreatic cancer and triple-negative breast cancer. It’s the approach City of Hope is taking with its newly launched multidisciplinary teams, br...
  • It’s a reasonable question: Why is the National Cancer Institute funding a study on preventing heart failure? The answer is reasonable as well: Rates of heart failure are drastically high among childhood cancer survivors — 15 times higher than among people the same age who were never treated for cancer. T...
  • Many teenagers take a break from academics during the summer, but not the eight high school students enrolled in the California Institute for Regenerative Medicine (CIRM) Creativity Awards program at City of Hope. They took the opportunity to obtain as much hands-on research experience as possible, learning fro...
  • About one in eight women will develop breast cancer at some point in her life. In fact, breast cancer is the most common cancer in American women, behind skin cancer. Although women can’t change some risk factors, such as genetics and the natural aging process, there are certain things they can do to lower thei...
  • As genetic testing becomes more sophisticated, doctors and their patients are finding that such tests can lead to the discovery of previously unknown cancer risks. In his practice at City of Hope, Thomas Slavin, M.D., an assistant clinical professor in the Division of Clinical Cancer Genetics, sees the full spe...
  • And the winners are … everyone in the San Gabriel Valley. The recipients of City of Hope’s first-ever Healthy Living grants have been announced, and the future is looking healthier already. In selecting San Gabriel Valley organizations to receive the grants, City of Hope’s Community Benefits Advisory Council ch...
  • Barry Leshowitz is a former City of Hope patient and a family advisor for the Sheri & Les Biller Patient and Family Resource Center. It’s been almost seven years since I checked into a local hospital in Phoenix for a hip replacement, only to be informed by the surgeon that he had canceled the surgery....
  • When it comes to science, the best graduate schools don’t just train scientists, they prepare their students for a lifetime of learning, accomplishment and positive impact on society. At City of Hope, the Irell & Manella Graduate School of Biological Sciences goes one step further – by preparing students to...
  • Cancer affects not just the cancer patient, but everyone around him or her, even after treatment is complete. The challenges can include the fear of cancer recurrence, coping with cancer’s economic impact and the struggle to achieve work-life balance post-treatment. Family members and loved ones of cancer patie...
  •   Bladder cancer facts: Bladder cancer is a disease in which malignant (cancer) cells form in the tissues of the bladder. 2015 estimates: 74,000 new cases of bladder cancer diagnosed 16,000 deaths from bladder cancer (about 11,510 in men and 4,490 in women) Risk factors for bladder cancer: Smoking: Smokers...
  • Women with ovarian cancer have questions about the most promising treatment options, revolutionary research avenues, survivorship and, of course, the potential impact on their personal lives. Now, together in one place, are experts who can provide answers. On Saturday, Sept. 12, the 2015 Ovarian Cancer Survivor...